A balanced pool of hematopoietic stem cells (HSCs) in bone marrow is tightly regulated, and this regulation is disturbed in hematopoietic malignancies such as chronic myeloid leukemia (CML). The underlying mechanisms are largely unknown. Here we show that the Lin(-)Sca-1(+)c-Kit(-) (LSK(-)) cell population derived from HSC-containing Lin(-)Sca-1(+)c-Kit(+) (LSK) cells has significantly higher numbers of apoptotic cells. Depletion of LSK cells by radiation or the cytotoxic chemical 5-fluorouracil results in an expansion of the LSK(-) population. In contrast, the LSK(-) population is reduced in CML mice, and depletion of leukemia stem cells (LSCs; BCR-ABL-expressing HSCs) by deleting Alox5 or by inhibiting heat shock protein 90 causes an incr...
SummaryUsing a mouse model recapitulating the main features of human chronic myelogenous leukemia (C...
AbstractFlt3 has emerged as a potential regulator of hematopoietic stem cells (HSC). Sixty percent o...
AbstractFas-deficient (Fas lpr/lpr) mice constitutively expressing Bcl-2 in myeloid cells by the hMR...
A balanced pool of hematopoietic stem cells (HSCs) in bone marrow is tightly regulated, and this reg...
<p>(<b>A</b>) LSK (Lin<sup>−</sup>Sca1<sup>+</sup>c-Kit<sup>+</sup>) cells (1×10<sup>3</sup>) and LS...
SummaryWe characterized leukemia stem cells (LSC) in chronic phase chronic myelogenous leukemia (CML...
<p>(<b>A</b>) BCR-ABL<sup>+</sup>LSK cells give rise to LSK<sup>−</sup> cells in CML mice. 1×10<sup>...
Hematopoietic Stem Cells (HSCs) have been defined to have abilities of both self-renewal and multi-l...
SummaryLeukemia stem cells (LSCs) represent a biologically distinct subpopulation of myeloid leukemi...
In chronic myeloid leukemia (CML), tyrosine kinase inhibitor (TKI) treatment induces autophagy that ...
<p>(<b>A</b>) The LSK<sup>−</sup> cell population is basically CD150-negative. LSK<sup>+</sup> (Lin<...
SummaryWe report here that in chronic lymphocytic leukemia (CLL), the propensity to generate clonal ...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
The presence of leukemic stem cells (LSC) in the bone marrow of patients with chronic myeloid leukem...
Studies on chronic myeloid leukemia (CML) have served as a paradigm for cancer research and therapy....
SummaryUsing a mouse model recapitulating the main features of human chronic myelogenous leukemia (C...
AbstractFlt3 has emerged as a potential regulator of hematopoietic stem cells (HSC). Sixty percent o...
AbstractFas-deficient (Fas lpr/lpr) mice constitutively expressing Bcl-2 in myeloid cells by the hMR...
A balanced pool of hematopoietic stem cells (HSCs) in bone marrow is tightly regulated, and this reg...
<p>(<b>A</b>) LSK (Lin<sup>−</sup>Sca1<sup>+</sup>c-Kit<sup>+</sup>) cells (1×10<sup>3</sup>) and LS...
SummaryWe characterized leukemia stem cells (LSC) in chronic phase chronic myelogenous leukemia (CML...
<p>(<b>A</b>) BCR-ABL<sup>+</sup>LSK cells give rise to LSK<sup>−</sup> cells in CML mice. 1×10<sup>...
Hematopoietic Stem Cells (HSCs) have been defined to have abilities of both self-renewal and multi-l...
SummaryLeukemia stem cells (LSCs) represent a biologically distinct subpopulation of myeloid leukemi...
In chronic myeloid leukemia (CML), tyrosine kinase inhibitor (TKI) treatment induces autophagy that ...
<p>(<b>A</b>) The LSK<sup>−</sup> cell population is basically CD150-negative. LSK<sup>+</sup> (Lin<...
SummaryWe report here that in chronic lymphocytic leukemia (CLL), the propensity to generate clonal ...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
The presence of leukemic stem cells (LSC) in the bone marrow of patients with chronic myeloid leukem...
Studies on chronic myeloid leukemia (CML) have served as a paradigm for cancer research and therapy....
SummaryUsing a mouse model recapitulating the main features of human chronic myelogenous leukemia (C...
AbstractFlt3 has emerged as a potential regulator of hematopoietic stem cells (HSC). Sixty percent o...
AbstractFas-deficient (Fas lpr/lpr) mice constitutively expressing Bcl-2 in myeloid cells by the hMR...